-
LATEST NEWS - 10 FEB 2021
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman
Read more
-
Study from Scripps using SpyTag/SpyCatcher for display of SARS-CoV-2 RBD on ferritin nanoparticles for vaccine development
Read more
-
SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in a Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19
Read more
-
Covid-19 vaccine candidates using SpyCatcher/SpyTag to display Spike protein on computationally designed particles and Bacteriophage VLPs
Read more